Quantum Biopharma Ltd. 6-K Filing
Ticker: QNTM · Form: 6-K · Filed: Dec 1, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Dec 1, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Quantum Biopharma Ltd. (ticker: QNTM) to the SEC on Dec 1, 2025.
How long is this filing?
Quantum Biopharma Ltd.'s 6-K filing is 1 pages with approximately 152 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-12-01 07:00:09
Filing Documents
- f6k_120125.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-25-007666.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: December 1, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated December 1, 2025